# ACT Lung Health Intervention: Phase Two

> **NCT06945120** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 50 (estimated)

## Conditions studied

- Smoking Cessation
- Smoking Behaviors
- Smoking, Tobacco
- Smoking, Cigarette
- Smoking (Tobacco) Addiction

## Interventions

- **BEHAVIORAL:** ACT Lung Health Intervention

## Key facts

- **NCT ID:** NCT06945120
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-04
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06945120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06945120, "ACT Lung Health Intervention: Phase Two". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT06945120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*